Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 362

1.

Renal anaemia treatment in haemodialysis patients in the Central and Eastern European countries in everyday clinical practice follow-up.

Malyszko J, Drozdz M, Zolkiewicz A, Rutkowski B.

Int Urol Nephrol. 2014 Jan;46(1):71-82. doi: 10.1007/s11255-012-0303-0. Epub 2012 Nov 8.

2.

Renal anemia treatment with ESA in hemodialysis patients in relation to early versus late referral in everyday clinical practice in Central and Eastern European countries: baseline data.

Malyszko J, Drozdz M, Zolkiewicz A, Rutkowski B.

Kidney Blood Press Res. 2012;35(1):58-67. doi: 10.1159/000330496. Epub 2011 Aug 26.

3.
4.

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

PMID:
20609178
5.

Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics.

Minutolo R, Locatelli F, Gallieni M, Bonofiglio R, Fuiano G, Oldrizzi L, Conte G, De Nicola L, Mangione F, Esposito P, Dal Canton A; REport of COmorbidities in non-Dialysis Renal Disease Population in Italy (RECORD-IT) Study Group..

Nephrol Dial Transplant. 2013 Dec;28(12):3035-45. doi: 10.1093/ndt/gft338. Epub 2013 Oct 21.

PMID:
24145459
6.

The impact of hyporesponsiveness to erythropoietin-stimulating agents on time-dependent mortality risk among CKD stage 5D patients: a single-center cohort study.

Ishigami J, Onishi T, Shikuma S, Akita W, Mori Y, Asai T, Kuwahara M, Sasaki S, Tsukamoto Y.

Clin Exp Nephrol. 2013 Feb;17(1):106-14. doi: 10.1007/s10157-012-0659-6. Epub 2012 Jul 3.

PMID:
22752396
7.

Effect of acetate-free biofiltration on the anaemia of haemodialysis patients: a prospective cross-over study.

Basile C, Giordano R, Montanaro A, De Maio PD, De Padova FD, Marangi AL, Semeraro A.

Nephrol Dial Transplant. 2001 Sep;16(9):1914-9.

PMID:
11522879
8.

Chronic dialysis-associated anaemia in end-stage renal disease: analysis of management in two French centres.

Perrinet M, Décaudin B, Champs BB, Heran I, Urbina MA, Lemaitre V, Azar R, Odou P.

J Clin Pharm Ther. 2010 Aug;35(4):395-400. doi: 10.1111/j.1365-2710.2009.01106.x.

PMID:
20831542
9.

A predictive algorithm for the management of anaemia in haemodialysis patients based on ESA pharmacodynamics: better results for less work.

Lines SW, Lindley EJ, Tattersall JE, Wright MJ.

Nephrol Dial Transplant. 2012 Jun;27(6):2425-9. doi: 10.1093/ndt/gfr706. Epub 2011 Dec 29.

PMID:
22207330
10.

Monthly administration of a continuous erythropoietin receptor activator provides efficient haemoglobin control in non-dialysis patients during routine clinical practice: results from the non-interventional, single-cohort, multicentre, SUPRA study.

Heidenreich S, Leistikow F, Zinn S, Baumann J, Atzeni A, Bajeski V, Dietzmann J, Dragoun GP; SUPRA Study Group..

Clin Drug Investig. 2012 Feb 1;32(2):99-110. doi: 10.2165/11594040-000000000-00000.

PMID:
22117178
11.

Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.

Teruel-Briones JL, Fernández-Lucas M, Rivera-Gorrin M, Ruiz-Roso G, Díaz-Domínguez M, Rodríguez-Mendiola N, Quereda-Rodríguez-Navarro C.

Nefrologia. 2013;33(5):640-9. doi: 10.3265/Nefrologia.pre2013.May.12038. English, Spanish.

12.

The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study.

Covic A, Mircescu G.

Nephrol Dial Transplant. 2010 Aug;25(8):2722-30. doi: 10.1093/ndt/gfq069. Epub 2010 Feb 26.

13.

Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study.

Fort J, Cuevas X, García F, Pérez-García R, Lladós F, Lozano J, Martín-Malo A; ANSWER study..

Nephrol Dial Transplant. 2010 Aug;25(8):2702-10. doi: 10.1093/ndt/gfq073. Epub 2010 Feb 22.

PMID:
20176608
14.

High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).

Verbeke N, Beguin Y, Wildiers H, Canon JL, Bries G, Bosly A, Van Belle S.

Support Care Cancer. 2012 Jan;20(1):23-8. doi: 10.1007/s00520-010-1045-0. Epub 2010 Nov 25.

PMID:
21107613
15.

Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.

McMahon LP, Kent AB, Kerr PG, Healy H, Irish AB, Cooper B, Kark A, Roger SD.

Nephrol Dial Transplant. 2010 Mar;25(3):920-6. doi: 10.1093/ndt/gfp584. Epub 2009 Nov 10.

PMID:
19906658
16.

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.

Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Roubert B, Nolen JG, Roger SD; FIND-CKD Study Investigators..

Nephrol Dial Transplant. 2014 Nov;29(11):2075-84. doi: 10.1093/ndt/gfu201. Epub 2014 Jun 2.

17.

Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, Greenwood R, Feldman HI, Port FK, Held PJ.

Nephrol Dial Transplant. 2004 Jan;19(1):121-32. Erratum in: Nephrol Dial Transplant. 2004 Jun;19(6):1666.

PMID:
14671047
18.

Effectiveness and safety of recombinant human erythropoietin beta in maintaining common haemoglobin targets in routine clinical practice in Europe: the GAIN study.

Rath T, Mactier RA, Weinreich T, Scherhag AW; GAIN Investigators..

Curr Med Res Opin. 2009 Apr;25(4):961-70. doi: 10.1185/03007990902784459 .

PMID:
19254204
19.

Iron supplementation in haemodialysis--practical clinical guidelines.

Silva J, Andrade S, Ventura H, Santos JP, Colaço S, Oliveira C, Ponce P.

Nephrol Dial Transplant. 1998 Oct;13(10):2572-7.

PMID:
9794562
20.

ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data.

Locatelli F, Covic A, Macdougall IC, Wiecek A; ORAMA Study Group..

J Nephrol. 2008 Jul-Aug;21(4):592-603.

PMID:
18651551

Supplemental Content

Support Center